Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Ann Surg. 2015 Jun;261(6):1114–1123. doi: 10.1097/SLA.0000000000000971

Table 10. Pulmonary Complication.

Variables N Univariable logistic regression Multivariable logistic regression

95% C.I for OR 95% C.I for OR


OR Lower Upper P-Value OR Lower Upper P-Value
Group
 A* 322 1.00
 B 386 0.65 0.46 0.93 0.017 0.66 0.46 0.94 0.022
Gender
 Male* 617 1.00
 Female 91 1.48 0.91 2.41 0.117
Age 708 1.03 1.01 1.05 0.001 1.03 1.01 1.05 0.001
Preoperative treatment
 No* 140 1.00
 Yes 568 0.64 0.42 0.97 0.033
Diabetes
 No* 597 1.00
 Yes 111 1.28 0.81 2.03 0.294
COPD
 No* 663 1.00
 Yes 45 1.92 1.02 3.63 0.045
CAD
 No* 589
 Yes 119 1.15 0.73 1.81 0.562
Histology
 Adenocarcinoma* 643 1.00 1.00
 Squamous cell carcinoma 65 1.42 0.81 2.50 0.226 1.77 0.92 3.38 0.087
Tumor location
 Upper/cervical/middle* 63 1.00
 Lower/GEJ 645 0.61 0.35 1.08 0.093
Type of esophagectomy 0.045 0.052
 Ivor Lewis* 462 1.00 1.00
 Transhiatal 59 1.61 0.88 2.95 0.126 1.36 0.73 2.54 0.329
 Total 49 2.30 1.24 1.30 0.009 2.27 1.20 4.29 0.011
 Minimal invasive 124 1.32 0.83 2.10 0.24 1.44 0.89 2.31 0.137
 N/A 14 2.20 0.72 6.73 0.17 2.48 0.80 7.74 0.117
Minimal invasive surgery
 No* 584 1.00
 Yes 124 1.13 0.72 1.77 0.594
Pathological stage
 0* 145 1.00
 I 149 0.77 0.45 1.32 0.34
 II 254 0.90 0.56 1.45 0.67
 III 144 0.77 0.44 1.33 0.346
 IV 16 1.75 0.60 5.15 0.31
Clinical stage
 0* 5 1.00
 I 108 0.55 0.09 3.47 0.52
 II 253 0.37 0.06 2.27 0.28
 III 314 0.48 0.08 2.92 0.42
 IV 28 0.50 0.07 3.63 0.49
ASA-risk scale
 1-2* 122 1.00
 3-4 586 1.21 0.75 1.95 0.442
Salvage operation
 No* 612
 Yes 96 1.62 1.01 2.60 0.045
*

Reference group.

Statistically significant for univariable analysis (p<0.25).

OR indicates odds ratio; CI, confidence interval; COPD, chronic pulmonary obstructive disease; CA, coronary artery disease; GEJ, gastroesophageal junction; ASA, American Society of Anesthesiologist.